Wells Fargo launches Siemens Healthineers Medical Equipment Finance Program.
Healthcare facilities nationwide looking to purchase new Siemens Healthineers products, including imaging equipment, now have a new channel for securing potential funding.
Wells Fargo announced Friday it is launching a vendor financing relationship with Siemens in an effort to provide more comprehensive financing options for U.S. hospitals and health systems. Wells Fargo Vendor Financial Services – a part of Wells Fargo Commercial Capital – will administer the program.
“Hospital and healthcare executives struggle with securing favorable terms for capital acquisition,” said David Pacitti, president and head of the Americas for Siemens Healthineers in a press statement. “Through the Wells Fargo Medical Equipment Finance Program, Siemens Healthnineers customers will be offered thorough and competitive financing options, which will assist with technology acquisition.”
The program is designed to provide benefits in two ways. The financial solutions can help customers have more on-hand cash, help them make in-budget purchases of new technologies, and facilitate important growth projects. Additionally, Wells Fargo will give the Siemens sales force competitive lease and loan products, comprehensive transaction support, and value-added services to assist with sales efforts.
With long-standing experience in healthcare financing, Wells Fargo has $43 billion in capital dedicated to the healthcare sector and more than $2 billion earmarked for equipment financing.
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.